GKOS
GLAUKOS Corp
NYSE · Healthcare · Medical - Devices · US
$242.48
+33.65%Forward multiples
Based on analyst estimates
- P/E forward
- 418.20x
- P/E 2026E
- —
- P/E 2027E
- 460.87x
- P/E 2028E
- 146.30x
- P/S forward
- 17.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 19.94x
- Price / sales
- 20.72x
- Price / cash flow
- 299.78x
Enterprise value
- Enterprise value
- $14.1B
- EV / sales
- 20.38x
- EV / EBITDA
- -103.80x
- EV / EBIT
- -222.25x
- Market cap
- $14.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026